Levothyroxine-Associated Thyrotoxicosis and Hyperbilirubinemia on Preoperative Screening Evaluation.
Document Type
Article
Publication Title
Case reports in endocrinology
Abstract
BACKGROUND: Levothyroxine is a commonly prescribed medication for treatment of hypothyroidism in the United States. This drug is titrated based on weight and serial laboratory evaluation and is often very well tolerated with few adverse effects. Levothyroxine-associated liver injury and cholestatic disease are regarded as rare phenomena. We report an additional case of levothyroxine-associated hepatic dysfunction with resolution upon decreased dosage and continued tolerance of the medication.
CASE PRESENTATION: We report a case of a 60-year-old male presenting for preoperative clearance for umbilical hernia repair with previous history of thyroidectomy for multinodular goiter. Laboratory work-up suggested thyrotoxicosis-associated hepatic dysfunction secondary to levothyroxine overtreatment with associated mixed hepatocellular and cholestatic pattern of injury. Extensive work-up failed to reveal other etiology of liver dysfunction and levothyroxine overtreatment was regarded as the likely cause. Complete resolution of the elevated hepatic enzymes occurred with decreased levothyroxine dosing and return of euthyroid state.
CONCLUSION: Although regarded as a rare phenomenon, levothyroxine use and drug-induced thyrotoxicosis should be considered as a possible etiology when evaluating hepatic dysfunction. This case highlights that levothyroxine may be safely continued following a dosing adjustment with noted resolution of hepatic enzyme abnormalities in certain clinical scenarios.
First Page
4776246
Last Page
4776246
DOI
10.1155/crie/4776246
Publication Date
1-1-2025
Recommended Citation
Suriano CJ, Erkkila IP, Vara TM. Levothyroxine-Associated Thyrotoxicosis and Hyperbilirubinemia on Preoperative Screening Evaluation. Case Rep Endocrinol. 2025 Dec 22;2025:4776246. doi: 10.1155/crie/4776246. PMID: 41446557; PMCID: PMC12723184.